NEW YORK, Aug. 21 – Myriad Genetics’ fiscal fourth-quarter revenues climbed 17 percent to $10.8 million from $9.2 million in the fourth quarter a year ago, pushed upwards by increasing revenue from sales of the company’s diagnostic products, the company said Tuesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.